Abbott Laboratories's market cap is currently $216.86B. The company's EPS TTM is $7.662; its P/E ratio is 16.27; and it has a dividend yield of 1.74%. Abbott Laboratories is scheduled to report earnings on January 22, 2025, and the estimated EPS forecast is $1.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 40.11B	$ 43.65B	$ 43.08B	$ 34.61B	$ 31.90B
Gross Profit	$ 22.13B	$ 24.51B	$ 24.54B	$ 19.61B	$ 18.67B
Operating Income	$ 6.48B	$ 8.36B	$ 8.43B	$ 5.36B	$ 4.53B
EBITDA	$ 10.61B	$ 12.38B	$ 12.74B	$ 8.79B	$ 7.77B
Net Income	$ 5.72B	$ 6.93B	$ 7.07B	$ 4.50B	$ 3.69B
Balance Sheet
Cash & Short-Term Investments	$ 7.28B	$ 10.17B	$ 10.25B	$ 7.15B	$ 4.14B
Total Assets	$ 73.21B	$ 74.44B	$ 75.20B	$ 72.55B	$ 67.89B
Total Debt	$ 15.87B	$ 17.72B	$ 19.01B	$ 19.65B	$ 18.89B
Net Debt	$ 8.98B	$ 7.83B	$ 9.21B	$ 12.81B	$ 15.03B
Total Liabilities	$ 34.39B	$ 37.53B	$ 39.17B	$ 39.55B	$ 36.59B
Stockholders' Equity	$ 38.60B	$ 36.69B	$ 35.80B	$ 32.78B	$ 31.09B
Cash Flow
Free Cash Flow	$ 5.06B	$ 7.80B	$ 8.65B	$ 5.72B	$ 4.50B
Operating Cash Flow	$ 7.26B	$ 9.58B	$ 10.53B	$ 7.90B	$ 6.14B
Investing Cash Flow	$ -3.13B	$ -1.74B	$ -2.01B	$ -2.21B	$ -1.81B
Financing Cash Flow	$ -7.09B	$ -7.64B	$ -5.49B	$ -2.78B	$ -4.29B

Currency in USD

Abbott Laboratories Earnings and Revenue History

Income Statement >

Abbott Laboratories Debt to Assets

Balance Sheet >

Abbott Laboratories Cash Flow

Cash Flow >

Abbott Laboratories Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing